Potential impact of new oral anticoagulants on the management of atrial fibrillation‐related stroke in primary care
ConclusionThe clinical and economic benefits of the new oral anticoagulants, along with appropriate risk stratification, may enable a higher number of patients with AF to receive effective and convenient prophylaxis for stroke prevention.
Source: International Journal of Clinical Practice - Category: Internal Medicine Authors: K. Harris, J. Mant Tags: Review Article Source Type: research
More News: Atrial Fibrillation | Coumadin | General Practices | Internal Medicine | Pradaxa | Primary Care | Stroke | Study | Vitamins | Warfarin